6.6.2 Bisphosphonates and other drugs affecting bone metabolism

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

334 library items in 6.6.2 Bisphosphonates and other drugs affecting bone metabolism

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

6: Endocrine system (remove) , 6.6 Drugs affecting bone metabolism (remove) , 6.6.2 Bisphosphonates and other drugs affecting bo (remove)

Sort by: Display summary:

Results 1 - 10 of 334

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

Psychometric properties of the Oteoporosis-Specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates

Source: Annals of Pharmacotherapy,
Date published: 15/05/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Bone Diseases | Compliance

NeLM Area:

Evidence > Medicines Management > References

Abstract link
2.

Perspective on safety and optimal duration of use of bisphosphonates

Source: New England Journal of Medicine (NEJM),
Date published: 10/05/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Adverse Drug Reactions | Osteoporosis

NeLM Area:

News

Link to FDA article

Link to article on duration
3.

Persistence and compliance of medications used in the treatment of osteoporosis - analysis using a large scale, representative, longitudinal German database

Source: International Journal of Clinical Pharmacology and Therapeutics,
Date published: 01/05/2012

Category:

6.6.1 Calcitonin and parathyroid hormone (contains Preotact entry) | 6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Compliance

NeLM Area:

Evidence > Medicines Management > References

Abstract link
4.

Horizon scanning: US FDA rejects denosumab (Xgeva) for preventing prostate cancer spread to bone

Source: Reuters Health News,
Date published: 30/04/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Cancer: prostate | Food &Drug Administration (FDA) | Licence extension

NeLM Area:

News

Link – registration required
5.

Inflammatory ocular adverse events with use of oral bisphosphonates: retrospective cohort study

Source: CMAJ ,
Date published: 05/04/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Adverse Drug Reactions | Ophthalmology

NeLM Area:

News

Abstract
6.

NICE issues Appraisal Consultation Document on denosumab for bone metastases from solid tumours

Source: NICE,
Date published: 30/03/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Cancer: breast | Cancer: prostate | Clinical guidelines | National Institute of Clinical Excellence (NICE) | Rheumatology

NeLM Area:

News

Link
7.

US FDA approves first generic ibandronate tablet (Boniva) for the prevention or treatment of post-menopausal osteoporosis

Source: US FDA,
Date published: 20/03/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Food &Drug Administration (FDA) | Menopause / hormone replacement therapy (HRT) | Osteoporosis

NeLM Area:

News

Link
8.

European CHMP issues positive opinions on generic versions of Aclasta and Zometa (zoledronic acid)

Source: EMA,
Date published: 16/03/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | European Agency for the Evaluation of Medicinal Products (EMEA) | Generic prescribing

NeLM Area:

News

Link Aclasta

Link Zometa
9.

US FDA approves soluble alendronic acid (Binosto) for osteoporosis in post-menopausal women

Source: BioSpace.com,
Date published: 15/03/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Food &Drug Administration (FDA) | Horizon scanning | Osteoporosis

NeLM Area:

News

Link
10.

Roche issues notification of divestment and related new distribution arrangements for Loron (clodronate disodium 520mg tablets)

Source: Roche Products Ltd,
Date published: 12/03/2012

Category:

6.6.2 Bisphosphonates and other drugs affecting bone metabolism | Pharmaceutical Industry | Prescribing and supply of medicines

NeLM Area:

News

Results 1 - 10 of 334

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next